EU seeks Moderna COVID vaccine deal at below $25 per dose-source

Moderna said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial.

Covid-19: Challenges of vaccinating a billion people
BRUSSELS, - The European Commission wants to reach a deal with Moderna for the supply of millions of doses of its COVID-19 vaccine candidate for a price below $25 per dose, an EU official involved in the talks said.

Moderna said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial. The EU has been in talks with Moderna for its experimental COVID-19 vaccine at least since July, an internal EU document seen by Reuters shows.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › News › International › World News › EU seeks Moderna COVID vaccine deal at below $25 per dose-source
Text Size:AAA
Success
This article has been saved

*

+